(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

V

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

V

ST13

US500000079294440

Class

1, 5, 10, 42

Filing

79294440

Registration

6504530

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

10/08/2022

Trademark type

Combined

Nice classes

1, 5, 10, 42

Filing date

08/03/2020

Registration date

10/05/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/05/2021

Last transaction

10/05/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

GB

Examiner

CIANCI, RYAN MICHAEL

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a "V" comprised of numerous dark shaded circles. A series of light shaded circles appear to the left of the "V".

Holders and representatives

Holders

VECTURA LIMITED

Representatives

Molly B. Markley Young, Basile, Hanlon & MacFarlane P.C.

Technical classification

Nice Classes

Class 1Class 5Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical additives for use in the manufacture of medical preparations

Class 5

Medical preparations for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical preparations for medical purposes for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; biological preparations for medical purposes for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical preparations for treating pulmonary diseases via inhalation; pharmaceutical preparations for the prevention and treatment of diseases and conditions of the respiratory and cardiovascular systems

Class 10

Medical apparatus and instrumentsnamely inhalers; drug delivery devicesnamely inhalers; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; component parts and fittings for all the aforesaid goods

Class 42

Scientific research relating to medical preparations and drug delivery devices; development and design medical preparations and drug delivery devices; analysisinvestigation in the form of testing of medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development

Publications

History of USPTO decisions and trademark events.

26 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/08/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/10/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/21/2022

FIMP

FINAL DISPOSITION PROCESSED

03/21/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/05/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/20/2021

PUBO

PUBLISHED FOR OPPOSITION

07/20/2021

GPNX

NOTIFICATION PROCESSED BY IB

07/19/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/30/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

06/30/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/30/2021

ALIE

ASSIGNED TO LIE

06/15/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/15/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/14/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/14/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/14/2021

RFNT

REFUSAL PROCESSED BY IB

01/04/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/16/2020

RFRR

REFUSAL PROCESSED BY MPU

12/16/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/03/2020

CNRT

NON-FINAL ACTION WRITTEN

12/02/2020

DOCK

ASSIGNED TO EXAMINER

11/24/2020

MAFR

APPLICATION FILING RECEIPT MAILED

10/03/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/29/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/24/2020

Continuous trademark protection

Get notified about every new filing that threatens V or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.